Evidence map›Paper›PMID 31439607›Full record

ArticleBMJ open2019

Anticholinergic burden and fractures: a protocol for a methodological systematic review and meta-analysis.

Jonas Reinold, Wiebke Schäfer, Lara Christianson, Francesco Barone-Adesi, Oliver Riedel, Federica Edith Pisa

Abstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jonas ReinoldLeibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.ORCID 0000-0001-8266-2574
Wiebke SchäferLeibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
Lara ChristiansonLeibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
Francesco Barone-AdesiDepartment of Pharmaceutical Sciences, University of Eastern Piedmont, Novara, Italy.
Oliver RiedelLeibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
Federica Edith PisaLeibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany pisa@leibniz-bips.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMedications with anticholinergic activity are used in the treatment of many diseases common in old age, including depression, psychosis, Parkinson's disease, allergies, pain and urinary incontinence. A high anticholinergic burden (ACB) is considered a major risk factor for fractures in older adults but recent studies reported inconsistent results. These inconsistencies may partly be due to differences in methodological aspects. However, no systematic review so far has addressed this association and considered study methods. Thus, we aim to conduct a systematic review and meta-analysis of observational studies addressing the association of ACB with fractures and to provide a methodological appraisal of the included studies. METHODS AND ANALYSIS: We will search MEDLINE, EMBASE, the Science Citation Index, CENTRAL and grey literature using a strategy that combines the terms anticholinergic and fractures. We will hand search reference lists of articles. Two reviewers will independently screen all identified abstracts for eligibility and evaluate the risk of bias of the included studies using the Newcastle-Ottawa Quality Assessment Scale and RTI item bank. Discrepancies will be resolved by consensus or consultation with a third researcher. We will conduct a meta-analysis, either for the overall population or for specific and more homogeneous subgroups, if the number of studies retrieved and their heterogeneity allows it. ETHICS AND DISSEMINATION: No ethics approval will be sought, as no original data will be collected for this review. Findings will be disseminated through peer-reviewed publication and conference presentations. PROSPERO REGISTRATION NUMBER: CRD42018116737.

Indexed as

Cholinergic AntagonistsFractures, BoneHumansMeta-Analysis as TopicSystematic Reviews as TopicCholinergic Antagonistsanticholinergic agentanticholinergic burdenfractures

Identifiers

PMID31439607
PMCPMC6707654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.